Top 16 Vascular Pharmaceuticals investors
The most complete profiles first. Showing 16 of 16.
Brian GoodmanVerified
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Gerry BrunkVerified
Venture Capital, Private Equity Firm, Micro VC · United States
Health CareWomen FoundedBiotechnologyLendingPortfolio: Cardiac Dimensions, Exact Imaging, Notch Therapeutics, Social Change Rewards and 36 more
Verified email available
Lu HanVerified
Venture Capital · Canada
Health CareWomen FoundedBiotechnologyDeveloper ToolsPortfolio: Cardiac Dimensions, Exact Imaging, Notch Therapeutics, Social Change Rewards and 36 more
Verified email available
Luke EvninVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Nikhil ThatteVerified
Venture Capital, Private Equity Firm, Micro VC · Canada
Health CareWomen FoundedBiotechnologyLendingPortfolio: Cardiac Dimensions, Exact Imaging, Notch Therapeutics, Social Change Rewards and 36 more
Verified email available
Shinichiro FuseVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Todd FoleyVerified
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Ed Hurwitz
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, Protego Biopharma, InformedDNA, Mitobridge and 60 more
Contact details available
Stephen Curtis
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Baye Galligan
Venture Capital, Private Equity Firm, Micro VC · Canada
Health CareWomen FoundedBiotechnologyLendingPortfolio: Cardiac Dimensions, Exact Imaging, Notch Therapeutics, Social Change Rewards and 36 more
Contact details available
Christiana Bardon M.D.
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsInvestment ManagementLife SciencePortfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Jacki Jenuth
Venture Capital · Canada
Health CareWomen FoundedBiotechnologyDeveloper ToolsPortfolio: Cardiac Dimensions, Exact Imaging, Notch Therapeutics, Social Change Rewards and 36 more
Contact details available
Leigh Zawel
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Richard Glickman
Venture Capital · Canada
Health CareWomen FoundedBiotechnologyDeveloper ToolsPortfolio: Cardiac Dimensions, Exact Imaging, Notch Therapeutics, Social Change Rewards and 36 more
Contact details available
Vasco Larcina
Venture Capital · Canada
Health CareWomen FoundedBiotechnologyDeveloper ToolsPortfolio: Cardiac Dimensions, Exact Imaging, Notch Therapeutics, Social Change Rewards and 36 more
Contact details available
Vinay Bhaskar
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
By investment stage
- Seed2
By location
Related industries
Most-backed portfolio companies
- Syndax Pharmaceuticals9
- Entrada Therapeutics9
- Iconic Therapeutics9
- Kalidex Pharmaceuticals9
- Cullinan Oncology9
- Selexys Pharmaceuticals Corporation9
- Celladon9
- Tetherex Pharmaceuticals9
- Oncorus9
- TriVascular9
- Trishula Therapeutics9
Frequently asked questions
How many Vascular Pharmaceuticals investors are on Angel Roster?
Angel Roster lists 16 Vascular Pharmaceuticals investors. 7 of them (44%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (16), Private Equity Firms (12) and Investment Partner Investors (3). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Vascular Pharmaceuticals investors invest in?
Among those that list a stage, the most common are Seed (2).
Where are Vascular Pharmaceuticals investors based?
Most are based in the United States (10) and Canada (6).
Which companies have Vascular Pharmaceuticals investors backed?
The most-backed portfolio companies among them are Syndax Pharmaceuticals (9), Entrada Therapeutics (9), Iconic Therapeutics (9), Kalidex Pharmaceuticals (9) and Cullinan Oncology (9).
How do I contact Vascular Pharmaceuticals investors?
Create a free Angel Roster account to search and filter all 16, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.